miliary tuberculosis

miliary tuberculosis
Name	Miliary tuberculosis
Field	Infectious disease, Pulmonology
Symptoms	Fever, weight loss, night sweats, dyspnea, hepatosplenomegaly
Complications	Meningitis, adrenal insufficiency, respiratory failure
Onset	Acute or subacute
Causes	Dissemination of Mycobacterium tuberculosis
Risks	Immunosuppression, HIV/AIDS, malnutrition

miliary tuberculosis Miliary tuberculosis is a form of disseminated Mycobacterium tuberculosis infection characterized by hematogenous spread producing numerous tiny lesions in multiple organs. It presents with systemic symptoms and multiorgan involvement and requires prompt recognition and treatment to reduce morbidity and mortality. Historical descriptions date from the era of Robert Koch's discovery of tubercle bacilli through 20th-century clinical series influenced by events such as the 1918 influenza pandemic and the rise of HIV/AIDS.

Overview

Miliary tuberculosis arises when Mycobacterium tuberculosis breaches local defenses and enters the bloodstream, seeding the lungs, liver, spleen, bone marrow, and central nervous system. The term “miliary” reflects the millet seed–like appearance of lesions on gross and radiologic examination noted in early pathologic atlases and reports from institutions like the Royal College of Physicians and the Johns Hopkins Hospital. Clinicians in settings influenced by outbreaks during the Great Depression and postwar eras recognized its protean manifestations, prompting advances in radiology at centers such as the Mayo Clinic and histopathology at the American Society of Pathologists.

Causes and Pathophysiology

The proximate cause is hematogenous dissemination of Mycobacterium tuberculosis from a primary pulmonary focus or reactivation lesion. Predisposing contexts include impaired cellular immunity seen with HIV/AIDS, immunosuppressive therapies used after transplantation at centers like Massachusetts General Hospital, and malnutrition observed during famines such as the Bengal famine of 1943. Pathophysiologically, infected macrophages and dendritic cells fail to contain bacilli, enabling spread through the pulmonary veins or lymphatics to systemic circulation; granuloma formation occurs variably in parenchymal organs, influenced by host responses described in work from investigators at the Pasteur Institute and the National Institutes of Health. Genetic susceptibilities identified in cohorts studied at institutions like Imperial College London and Karolinska Institutet modulate cytokine pathways, including interferon-gamma and interleukin-12 axes, implicated in disseminated disease in historical case series compiled at the London School of Hygiene & Tropical Medicine.

Clinical Presentation

Patients commonly report prolonged fever, weight loss, night sweats, and malaise; respiratory symptoms range from cough to progressive dyspnea. Physical signs often reflect multiorgan involvement such as hepatosplenomegaly, lymphadenopathy, and signs of meningitis if the central nervous system is involved—patterns documented in case reports from the Royal Free Hospital and pediatric series from Great Ormond Street Hospital. In neonates and elderly patients, presentations may be nonspecific, complicating recognition in settings including refugee camps documented by Doctors Without Borders and public health responses coordinated by the World Health Organization.

Diagnosis

Diagnosis integrates clinical suspicion with laboratory, radiologic, and histopathologic data. Chest radiography or computed tomography may reveal innumerable small nodules; bone marrow, liver biopsy, or lymph node sampling can demonstrate granulomas and acid-fast bacilli, techniques refined at centers like the Mayo Clinic and John Radcliffe Hospital. Microbiologic confirmation uses culture systems developed at the Statens Serum Institut and molecular assays such as nucleic acid amplification tested in trials at the Centers for Disease Control and Prevention; interferon-gamma release assays and tuberculin skin testing have limitations in immunocompromised hosts, as shown in studies from St Thomas' Hospital and Addenbrooke's Hospital.

Treatment

Treatment follows multidrug antituberculous regimens combining isoniazid, rifampicin, pyrazinamide, and ethambutol or streptomycin, informed by clinical trials at institutions such as Imperial College London and the University of Cape Town. Duration and adjunctive corticosteroids are guided by site involvement (e.g., central nervous system disease) and by protocols developed by the World Health Organization and national programs like those at the Centers for Disease Control and Prevention. Management of drug-resistant disease relies on second-line agents and individualized regimens pioneered in specialist units at the Royal Brompton Hospital and the Torbay Hospital with support from global collaborations including the Stop TB Partnership.

Prognosis and Complications

Prognosis varies: prompt diagnosis and effective therapy yield favorable outcomes in many patients, while delayed treatment, multidrug resistance, or coexisting HIV/AIDS worsen mortality—patterns documented in cohort studies from South Africa, India, and Russia. Major complications include tuberculous meningitis, adrenal insufficiency (Addisonian crisis), miliary involvement of the liver leading to hepatic failure, and respiratory failure necessitating intensive care at tertiary centers like Royal Infirmary of Edinburgh. Long-term sequelae reported in follow-up studies from the Karolinska University Hospital include chronic pulmonary impairment and persistent neurologic deficits.

Epidemiology and Risk Factors

Miliary tuberculosis incidence reflects global tuberculosis prevalence and risk modifiers: highest rates occur in regions with high Mycobacterium tuberculosis transmission such as parts of Sub-Saharan Africa, South Asia, and areas affected by humanitarian crises documented by United Nations High Commissioner for Refugees. Risk factors include HIV/AIDS, diabetes mellitus—addressed in public health initiatives by the World Health Organization and Global Fund—malnutrition, young age, advanced age, and immunosuppression from therapies for malignancy or transplantation at centers like MD Anderson Cancer Center and Cleveland Clinic. Surveillance data compiled by agencies such as the Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control guide control strategies and vaccine research at institutions including the Bill & Melinda Gates Foundation–funded consortia.

Category:Tuberculosis